Home

foulée Serment Triangle diasorin spa azioni classique dominer Équiper

Untitled
Untitled

Contact us - DiaSorin Molecular
Contact us - DiaSorin Molecular

DiaSorin - The Diagnostic Specialist
DiaSorin - The Diagnostic Specialist

DiaSorin Molecular Gets More BARDA Funding to Submit Covid-19 Kits for FDA  Clearance | Clinical Lab Products
DiaSorin Molecular Gets More BARDA Funding to Submit Covid-19 Kits for FDA Clearance | Clinical Lab Products

Urgent Field Safety Notice Urgent Field Safety Notice
Urgent Field Safety Notice Urgent Field Safety Notice

DIASORIN S.P.A. ANNOUNCES ITS INTENTION TO OFFER € 500 MILLION SENIOR  UNSECURED EQUITY-LINKED BONDS DUE 2028 MARCH 31, 2021 S
DIASORIN S.P.A. ANNOUNCES ITS INTENTION TO OFFER € 500 MILLION SENIOR UNSECURED EQUITY-LINKED BONDS DUE 2028 MARCH 31, 2021 S

Untitled
Untitled

Comunicato Stampa
Comunicato Stampa

DiaSorin - The Diagnostic Specialist
DiaSorin - The Diagnostic Specialist

Results | DiaSorin
Results | DiaSorin

GpèfpèfpfggfldSemestrale 2011
GpèfpèfpfggfldSemestrale 2011

Medical Countermeasures | USA Public Health Security
Medical Countermeasures | USA Public Health Security

1 DiaSorin S.p.A. Autorizzazione all'acquisto e disposizione di azioni  proprie, ai sensi del combinato disposto degli artt. 2357
1 DiaSorin S.p.A. Autorizzazione all'acquisto e disposizione di azioni proprie, ai sensi del combinato disposto degli artt. 2357

Notice pursuant to article 143-quater, paragraph 5, of Consob Regulation  no. 11971/99 Saluggia, July 28th, 2016 - List of Shar
Notice pursuant to article 143-quater, paragraph 5, of Consob Regulation no. 11971/99 Saluggia, July 28th, 2016 - List of Shar

Comunicato Stampa
Comunicato Stampa

DiaSorin completes acquisition of Luminex - July 14, 2021 - YouTube
DiaSorin completes acquisition of Luminex - July 14, 2021 - YouTube